IL6 and esophageal squamous cell carcinoma: Subsequent COX regression analysis identified plasma IL-6 represents an independent risk factor for OS and PFS in advanced ESCC patients treated with PD-1 inhibitors after correcting for confounding variables, including the number of distant metastatic organs, ECOG scores, and treatment lines, which can be used to predict patient prognosis.